---
title: "HERSKOWITZ NEIL — Ownership Dossier"
canonical: https://whiteintel.dev/entity/6fa83efa-020d-54cd-aa9a-12efe4c94fbf
json: https://whiteintel.dev/api/public/dossier/6fa83efa-020d-54cd-aa9a-12efe4c94fbf
identifier: sec:0001298246
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# HERSKOWITZ NEIL

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001298246`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/6fa83efa-020d-54cd-aa9a-12efe4c94fbf  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/6fa83efa-020d-54cd-aa9a-12efe4c94fbf  

## Ownership & control

### Holdings / subsidiaries

- **TG THERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/9c13e806-71d9-5ea4-8db4-d751fc718108
- **CHELSEA THERAPEUTICS INTERNATIONAL, LTD.** (director) — https://whiteintel.dev/entity/37e41909-21b7-5963-805b-58f032deecde
- **Journey Medical Corp** (director) — https://whiteintel.dev/entity/80477041-705d-5644-800f-f2e7e0a19b36
- **MUSTANG BIO, INC.** (director) — https://whiteintel.dev/entity/3fc122f9-6400-5305-b3a1-eb2ec007494a
- **Checkpoint Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/35f3dc6d-8b4c-5267-a993-1465396a0556
- **AVENUE THERAPEUTICS, INC.** (director) — https://whiteintel.dev/entity/38869865-2929-5ffd-b1b7-9c8ba18dd3b8
- **NATIONAL HOLDINGS CORP** (director) — https://whiteintel.dev/entity/295ae329-49b0-5a50-af26-7766df8827e3
- **CB PHARMA ACQUISITION CORP.** (director) — https://whiteintel.dev/entity/e3e56cd2-a2df-5f1e-a30f-accb41274527
- **CYTRX ONCOLOGY CORP** (director) — https://whiteintel.dev/entity/aeb88441-9d88-5c55-9bdc-509d51b59216

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **HERSKOWITZ NEIL**. Human view: https://whiteintel.dev/entity/6fa83efa-020d-54cd-aa9a-12efe4c94fbf · Structured JSON: https://whiteintel.dev/api/public/dossier/6fa83efa-020d-54cd-aa9a-12efe4c94fbf._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._